Silicon Valley telemedicine enterprise Hims Inc., which received reputation promoting erectile dysfunction and hair loss remedies on-line, is nearing a deal to move public via a merger with blank-check enterprise Oaktree Acquisition Corp., according to people with expertise of the matter.
The deal, which can be introduced as quickly as subsequent week, could value Hims at about $1.6 billion, stated the people, who requested not to be diagnosed due to the fact the information are private. Oaktree is in talks with buyers to raise about $seventy five million to assist fund the transaction, the people stated.
Hims is best recognized for providing on-line prescriptions to deal with situations that patients is probably shy to go to an in-person provider for, which includes hair loss and sexual disorder. Patients whole an internet session with a medical doctor and soon after acquire a Hims-branded prescription in the mail.
The enterprise additionally sells its personal skin care merchandise and vitamins. Hims Inc. has a parallel commercial enterprise for women, known as Hers.
Hims has raised $197 million from buyers such as Institutional Venture Partners, Forerunner Ventures, Redpoint Ventures and Josh Kushner’s Thrive Capital. Founded in 2017, the enterprise become valued at $1.1 billion in 2019, in line with PitchBook.
Oaktree, sponsored by global asset manager Oaktree Capital Group, is a special purpose acquisition enterprise, or SPAC, which raised $2 hundred million as a part of its preliminary public offering closing year.
Hims is the ultra-modern startup trying to move public via a SPAC. The funding automobiles have received reputation this year, presenting a brief path for corporations seeking to move public with out the scrutiny or dangers of an IPO. This month, property startup Opendoor introduced a $4.eight billion merger with a blank-check enterprise.
